Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#131 / 145 Total
RANI - Rani Therapeutics Holdings Inc - Stock Price Chart
TickerRANI [NASD]
CompanyRani Therapeutics Holdings Inc
CountryUSA
IndustryBiotechnology
Market Cap152.01MEPS (ttm)-1.29
P/E-EPS this Y8.81%
Forward P/E-EPS next Y12.74%
PEG-EPS past 5Y0.28%
P/S-EPS next 5Y-9.40%
P/B20.54EPS Q/Q13.36%
Dividend-Sales Q/Q-
Insider Own56.64%Inst Own7.99%
Insider Trans0.58%Inst Trans6.68%
Short Float10.86%EarningsMay 06/a
Analyst Recom1.00Target Price11.00
Avg Volume146.61K52W Range1.82 - 8.75
Rani Therapeutics Holdings, Inc. engages in the operation of a clinical stage bio-therapeutics company. The company was founded by Mir Imran on February 21, 2012 and is headquartered in San Jose, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Imran TalatChief Executive OfficerDec 06 '23Buy2.2710,00022,700484,455Dec 07 05:18 PM
Imran TalatChief Executive OfficerDec 04 '23Buy2.575,00012,850474,455Dec 06 08:00 AM
Imran TalatChief Executive OfficerNov 29 '23Buy2.0520,00041,000469,455Dec 01 08:00 AM
South Cone Investments Limited10% OwnerNov 24 '23Buy2.015,265,16510,582,98212,131,554Dec 08 04:27 PM
Quiroga Cortes Isidoro Alfonso10% OwnerNov 24 '23Sale2.015,265,16510,582,9828,400Dec 08 04:29 PM
BCTX - BriaCell Therapeutics Corp - Stock Price Chart
TickerBCTX [NASD]
CompanyBriaCell Therapeutics Corp
CountryCanada
IndustryBiotechnology
Market Cap33.72MEPS (ttm)-1.67
P/E-EPS this Y-6.92%
Forward P/E-EPS next Y-0.72%
PEG-EPS past 5Y32.71%
P/S-EPS next 5Y-
P/B-EPS Q/Q7.71%
Dividend-Sales Q/Q-
Insider Own12.15%Inst Own14.03%
Insider Trans0.00%Inst Trans-
Short Float4.76%EarningsMar 19/b
Analyst Recom1.00Target Price18.00
Avg Volume69.09K52W Range2.01 - 7.59
Apr-24-24 08:00AM BriaCell Announces Oral and Poster Presentations at ASCO 2024 (GlobeNewswire) -5.60%
Apr-10-24 08:00AM BriaCell 2024 AACR Preclinical Poster Confirms Strong Anti-Cancer Activity of Bria-OTS+ and Bria-PROS+ Clinical Candidates for Breast and Prostate Cancer (GlobeNewswire)
Apr-09-24 08:00AM BriaCell Showcases Data Demonstrating Unmatched Progression-Free Survival (PFS) and Clinical Efficacy in Antibody-Drug Conjugate (ADC) Resistant and Central Nervous System (CNS) Metastatic Breast Cancer at the 2024 AACR (GlobeNewswire)
Mar-19-24 06:52AM BCTX Stock Earnings: BriaCell Therapeutics Reported Results for Q2 2024 (InvestorPlace) -6.55%
Mar-07-24 08:00AM BriaCell Receives and Executes Letter of Intent to Advance Clinical Development of Breast and Prostate Cancer Immunotherapies (GlobeNewswire) -7.05%
Mar-06-24 08:00AM BriaCell to Present Clinical Data in Central Nervous System (CNS) Metastasis and Antibody-Drug Conjugate (ADC) Resistant Breast Cancer at the 2024 AACR Conference (GlobeNewswire) -8.24%
Feb-27-24 08:00AM BriaCell Provides Update on Alleged Illegal Trading of Public Securities (GlobeNewswire)
Feb-07-24 08:00AM BriaCell Announces Strong Clinical Data in Breast Cancer Patients; Reports Another Notable Responder Case (GlobeNewswire)
Feb-06-24 08:30AM Breaking Ground in Prostate Cancer: BriaCell Announces Lead Prostate Cancer Candidate Bria-Pros+, Initiates GMP Manufacturing (GlobeNewswire) +5.34%
Jan-30-24 10:48PM BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting (GlobeNewswire)
BriaCell Therapeutics Corp. is an immuno-oncology biotechnology company, which engages in the development of immunotherapies for the treatment of cancer. Its technologies include Bria-IMT and Bria-OTS. The company was founded by Charles L. Wiseman and Isaac B. Maresky on July 26, 2006 and is headquartered in West Vancouver, Canada.
ANEB - Anebulo Pharmaceuticals Inc - Stock Price Chart
TickerANEB [NASD]
CompanyAnebulo Pharmaceuticals Inc
CountryUSA
IndustryBiotechnology
Market Cap59.12MEPS (ttm)-0.41
P/E-EPS this Y5.67%
Forward P/E-EPS next Y-24.06%
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B9.11EPS Q/Q29.40%
Dividend-Sales Q/Q-
Insider Own64.22%Inst Own28.19%
Insider Trans0.00%Inst Trans46.41%
Short Float0.19%EarningsFeb 13/a
Analyst Recom1.00Target Price6.00
Avg Volume6.05K52W Range1.62 - 4.05
Anebulo Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the provision of pharmaceutical services. Its product candidate, ANEB-001, is currently in phase two of trial. The company was founded by Joseph F. Lawler on April 23, 2020 and is headquartered in Lakeway, TX.
MNDR - Mobile health Network Solutions - Stock Price Chart
TickerMNDR [NASD]
CompanyMobile health Network Solutions
CountrySingapore
IndustryHealth Information Services
Market Cap77.86MEPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own53.46%Inst Own-
Insider Trans0.00%Inst Trans-
Short Float7.07%Earnings-
Analyst Recom1.00Target Price8.00
Avg Volume5.49M52W Range2.21 - 29.50
Mobile-health Network Solutions operates as an investment holding company. The company through its subsidiaries provides telehealth solutions through MaNaDr platform. The platform seeks to offer users the ability to teleconsult with doctors and prescribed and delivered with the medication at their doorsteps. The company's segments include: Telemedicine and Other Services, and Sale of Medicine and Medical Devices. The Telemedicine and Other Services segment includes providing teleconsultation services to patients from both private and public sector. The Sale of Medicine and Medical Devices segment focuses on selling prescription drugs, non-prescription drugs, and healthcare products to clinics and end customers offline and online. The company was founded by Tung Yeng Siaw and Pui Pui Teoh on July 28, 2016 and is headquartered in Singapore.
DMAC - DiaMedica Therapeutics Inc - Stock Price Chart
TickerDMAC [NASD]
CompanyDiaMedica Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap114.64MEPS (ttm)-0.55
P/E-EPS this Y-14.44%
Forward P/E-EPS next Y-25.24%
PEG-EPS past 5Y4.28%
P/S-EPS next 5Y30.00%
P/B2.47EPS Q/Q31.91%
Dividend-Sales Q/Q-
Insider Own37.35%Inst Own11.62%
Insider Trans0.14%Inst Trans-10.82%
Short Float0.77%EarningsMay 08/a
Analyst Recom1.00Target Price7.00
Avg Volume42.23K52W Range1.67 - 4.75
DiaMedica Therapeutics, Inc. operates as a clinical stage biopharmaceutical company, which engages in the development of novel recombinant proteins. It develops the DM199 product candidate, which focuses on acute ischemic stroke (AIS) and chronic kidney disease (CKD). The company was founded by Wayne Lautt on January 21, 2000 and is headquartered in Minneapolis, MN.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Wambeke David J.Chief Business OfficerNov 16 '23Buy2.4620,00049,200527,114Nov 16 04:37 PM
Von Koch Thomas10% OwnerJun 23 '23Buy3.401,470,5884,999,9994,326,435Jun 27 04:11 PM
Giuffre Randall MichaelDirectorJun 23 '23Buy3.9165,000254,150360,355Jun 26 04:42 PM
Wambeke David J.Chief Business OfficerJun 23 '23Buy3.9138,364150,003507,114Jun 26 04:14 PM
Pilnik Richard D.DirectorJun 23 '23Buy3.9138,363149,999248,245Jun 26 04:03 PM
TSBX - Turnstone Biologics Corp - Stock Price Chart
TickerTSBX [NASD, RUT]
CompanyTurnstone Biologics Corp
CountryUSA
IndustryBiotechnology
Market Cap66.38MEPS (ttm)-3.27
P/E-EPS this Y30.20%
Forward P/E-EPS next Y3.50%
PEG-EPS past 5Y-
P/S-EPS next 5Y21.20%
P/B0.83EPS Q/Q-
Dividend-Sales Q/Q-100.00%
Insider Own29.40%Inst Own32.72%
Insider Trans0.00%Inst Trans-
Short Float4.23%EarningsMay 13/a
Analyst Recom1.67Target Price13.00
Avg Volume183.73K52W Range1.62 - 13.20
Turnstone Biologics Corp. operates as a clinical stage biotechnology company. It engages in the business of developing and commercializing therapeutics. The company is focused on developing new medicines to treat and cure patients with solid tumors. Turnstone Biologics was founded in 2015 and is headquartered in La Jolla, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Jerel DavisDirectorJul 25 '23Buy12.00225,0002,700,0002,726,322Jul 27 04:21 PM
Versant Ventures V, LLC10% OwnerJul 25 '23Buy12.00225,0002,700,0002,726,322Jul 27 04:23 PM
ORBIMED ADVISORS LLCDirectorJul 20 '23Buy12.00416,6664,999,9923,099,265Jul 24 04:38 PM
Gupta RishiDirectorJul 20 '23Buy12.00416,6664,999,9923,099,265Jul 24 04:40 PM
EZGO - EZGO Technologies Ltd - Stock Price Chart
TickerEZGO [NASD]
CompanyEZGO Technologies Ltd
CountryChina
IndustryRecreational Vehicles
Market Cap4.59MEPS (ttm)-0.18
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S0.29EPS next 5Y-
P/B2.90EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own6.98%Inst Own0.89%
Insider Trans0.00%Inst Trans-54.01%
Short Float16.03%Earnings-
Analyst Recom-Target Price-
Avg Volume602.98K52W Range1.52 - 110.80
EZGO Technologies Ltd. operates as a holding company, which engages in selling e-bicycle and battery cells. It operates through the following segments: Battery Cells and Packs, E-Bicycle Sales, Electric Control System and Intelligent Robots Sales. The Battery Cells and Packs Sales segment involves in selling battery packs. The E-Bicycle Sales segment includes selling e-bicycles offline to regional distributors and wholesalers and in online e-commerce platforms to individual customers. The Electronic Control System and Intelligent Robots Sales segment sells customized electronic control system and intelligent robot. The company was founded on January 24, 2019 and is headquartered in Changzhou, China.
TPCS - Techprecision Corp - Stock Price Chart
TickerTPCS [NASD]
CompanyTechprecision Corp
CountryUSA
IndustryMetal Fabrication
Market Cap36.13MEPS (ttm)-0.34
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-25.29%
P/S1.18EPS next 5Y-
P/B2.71EPS Q/Q-767.57%
Dividend-Sales Q/Q-8.14%
Insider Own8.09%Inst Own18.13%
Insider Trans0.00%Inst Trans-
Short Float0.09%EarningsNov 20/a
Analyst Recom-Target Price-
Avg Volume30.25K52W Range2.85 - 8.33
Techprecision Corp. engages in the business of metal fabrication and precision machining. It focuses on the manufacture of precision, large-scale fabricated and machined metal components and systems. The company was founded by Andrew A. Levy in February 2005 and is headquartered in Westminster, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Sammons ThomasChief Financial OfficerJul 13 '23Option Exercise0.68125,00085,000134,298Jul 17 04:05 PM
TTOO - T2 Biosystems Inc - Stock Price Chart
TickerTTOO [NASD]
CompanyT2 Biosystems Inc
CountryUSA
IndustryDiagnostics & Research
Market Cap36.57MEPS (ttm)-16.49
P/E-EPS this Y73.35%
Forward P/E-EPS next Y72.14%
PEG-EPS past 5Y68.62%
P/S5.09EPS next 5Y-
P/B-EPS Q/Q97.98%
Dividend-Sales Q/Q-0.82%
Insider Own0.00%Inst Own2.10%
Insider Trans-Inst Trans12.01%
Short Float6.74%EarningsMay 06/a
Analyst Recom3.00Target Price3.50
Avg Volume286.70K52W Range2.60 - 70.00
T2 Biosystems, Inc. is a vitro diagnostics company, which engages in the development of detection of sepsis-causing pathogens. It offers T2Dx instrument, T2Bacteria, T2Candida, T2Biothreat panels, and T2MR technology. The company was founded by Michael J. Cima, Robert S. Langer Jr., Tyler Jacks, Lee Josephson, W. David Lee, and Ralph Weissleder on April 27, 2006 and is headquartered in Lexington, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
CR Group L.P.10% OwnerSep 28 '23Sale0.167,148,9451,125,9590Sep 29 04:30 PM
CR Group L.P.10% OwnerSep 27 '23Sale0.195,981,2021,145,998571,796Sep 29 04:30 PM
CR Group L.P.10% OwnerSep 26 '23Sale0.205,392,9201,082,3591,050,192Sep 28 04:30 PM
CR Group L.P.10% OwnerSep 25 '23Sale0.25250,00062,5001,481,535Sep 27 05:53 PM
CR Group L.P.10% OwnerSep 22 '23Sale0.265,079,3441,314,5341,501,531Sep 26 05:15 PM
HGAS - Global Gas Corp - Stock Price Chart
TickerHGAS [NASD]
CompanyGlobal Gas Corp
CountryUSA
IndustrySpecialty Chemicals
Market Cap10.33MEPS (ttm)-0.07
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q112.14%
Dividend-Sales Q/Q-
Insider Own86.27%Inst Own8.17%
Insider Trans0.00%Inst Trans37.70%
Short Float3.19%Earnings-
Analyst Recom-Target Price-
Avg Volume93.25K52W Range1.05 - 10.66
Global Gas Corporation engages in the development and supply of nascent pure-play hydrogen, carbon and industrial gas. The company was Founded in 1989 and is headquartered in New York, NY.
19101112131415